Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple MyelomaGuillemette Fouquet, Xavier Leleu, Stéphanie Guidez et al.|Clinical Cancer Research|2014Cited by 74
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myelomaEileen M. Boyle, Xavier Leleu, Guillemette Fouquet et al.|Cancer|2014Cited by 36
Efficacy and safety profile of long‐term exposure to lenalidomide in patients with recurrent multiple myelomaGuillemette Fouquet, Xavier Leleu, Stéphanie Tardy et al.|Cancer|2013Cited by 31
Lenalidomide is safe and active in <scp>W</scp>aldenström macroglobulinemiaGuillemette Fouquet, Xavier Leleu, Stéphanie Guidez et al.|American Journal of Hematology|2015Cited by 26
Response to pneumococcal vaccination in multiple myelomaLoïc Renaud, Xavier Leleu, Susanna Schraen et al.|Cancer Medicine|2019Cited by 24